Fig. 1
From: Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer
Survival of different subgroups of colorectal cancer (CRC) patients. a Schematic depicting criteria for inclusion in the retrospective analysis and b representative images of CD177− or CD177+ scored metastases. c Kaplan–Meier curves of patients who received bev in their history stratified for CD177 score on TMAs of CRC metastasis (lymph node and organ metastases) or d who received a bev-free treatment regimen in their history stratified for CD177 score on TMAs of metastasis (lymph node and organ metastases). e–g Survival curves of samples derived from e lymph node metastases only or f liver metastases or g lung and liver metastases. The p values were determined by log-rank testing
